Clinical trials: Multiple Sclerosis Acute and Progressive

1 study

Multiple Sclerosis
Effects of Acthar on Recovery From Cognitive Relapses in MS
- Completed
- Age: 18 to 65 years
- Phase 3
- Results posted
The purpose of this study is to evaluate the effect of a medication called Acthar on recovery from multiple sclerosis-related relapses that impact cognition.
Trial name
NCT02290444
Testing
Adrenocorticotropic Hormone
Where
United States
Volunteers
64 people
Sponsor
State University of New York at Buffalo
Can I take part? NCT02290444Updated 6 Apr 2020